Terms: = Skin cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Prognosis
7 results:
1. Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
Marcon IG; Valsecchi D; Durso L; Premoli E; Sangiorgi D; Perrone V; Catena L; Degli Esposti L
Adv Ther; 2023 Sep; 40(9):3875-3895. PubMed ID: 37368101
[TBL] [Abstract] [Full Text] [Related]
2. Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus.
Zhu F; Li F; Xie X; Wu Y; Wang W
Cancer Med; 2023 Jun; 12(12):13290-13299. PubMed ID: 37132252
[TBL] [Abstract] [Full Text] [Related]
3. Identification of prognostic alternative splicing signatures in uveal melanoma.
Xie X; Zheng X; Xie T; Cai J; Yao Y
Int Ophthalmol; 2021 Apr; 41(4):1347-1362. PubMed ID: 33479809
[TBL] [Abstract] [Full Text] [Related]
4. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum.
Lehmann AR; Fassihi H
DNA Repair (Amst); 2020 Sep; 93():102907. PubMed ID: 33087273
[TBL] [Abstract] [Full Text] [Related]
5. Influence of functional variants Asp312Asn and Lys751Gln of Xeroderma Pigmentosum Group D (xpd) and Glutathione S-transferase Mu 1 (GSTM1) and Theta 1 (GSTT1) genes on cutaneous melanoma susceptibility and prognosis.
Rinck-Junior JA; Torricelli C; Gomez GVB; Oliveira C; Moraes AM; Lourenço GJ; Lima CSP
Exp Dermatol; 2019 May; 28(5):631-635. PubMed ID: 30883948
[TBL] [Abstract] [Full Text] [Related]
6. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
[TBL] [Abstract] [Full Text] [Related]
7. ERCC5 p.Asp1104His and ercc2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma.
Schrama D; Scherer D; Schneider M; Zapatka M; Bröcker EB; Schadendorf D; Ugurel S; Kumar R; Becker JC
J Invest Dermatol; 2011 Jun; 131(6):1280-90. PubMed ID: 21390047
[TBL] [Abstract] [Full Text] [Related]
